SPONF yields 20000000.00% · JNJ yields 2.13%● Live data
📍 SPONF pulled ahead of the other in Year 1
Combined, SPONF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SPONF + JNJ for your $10,000?
SponsorsOne Inc., a technology company, develops and operates a cloud-based social sponsorship platform in the United States and Canada. The company develops SponsorsCloud, a platform for connecting and facilitating one-to-one engagement between corporations and users within social networks. It also operates SponsorCoin, a platform that integrates with social networks and enables the delivery of social media marketing campaigns into the social channels, and facilitates transactions through its proprietary platform, which supports the exchange of goods and services between brands and influencers using its digital currency SponsorCoin. In addition, the company manufactures and develops spirits and ready-to-drink spirits, gin, and vodka under the Meet Doc Wylder's, Smithville, Four Corners, and Riverview brands; and hemp smokes under the Primero, Suede, and Reign brands. The company is headquartered in Uxbridge, Canada. SponsorsOne Inc. is a subsidiary of The Gummy Project Inc.
Full SPONF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.